T0901317 |
Agonist of NR1H2, NR1H3
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| NR1H2 |
|
|
| NR1H3 |
|
|
Agonist
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
In a panel of hormone receptors, 10 uM T0901317 showed activity against LXR-alpha>LXR-beta>PXR and n ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
In a panel of hormone receptors, 10 uM T0901317 showed activity against LXR-alpha>LXR-beta>PXR and n ...
Selectivity Assessment Description:
In a panel of hormone receptors, 10 uM T0901317 showed activity against LXR-alpha>LXR-beta>PXR and n ...
Potency Cellular
In Vitro
NR1H2
Mode of Action: Agonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1126/science.289.5484.1524
NR1H3
Mode of Action: Agonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1126/science.289.5484.1524
In Vivo Validations
Mouse
Dose: 10 mg/Kg PO, 20 mg/Kg IP, 50 mg/Kg IP
Route of delivery:
Intraperitoneal, Oral
Plasma half life:
4.9 (S), 3.3 (L), 4.5 (B) h
Organ of interest (O):
Serum , Liver, Brain
Target engagement assay:
T0901317 increased plasma triglycerides and HDL cholesterol.
DOI Reference: 10.1126/science.289.5484.1524
Orthogonal Probes def
GW3965
Chemical Information
| Molecular Formula | C17H12F9NO3S |
| SMILEs | O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1 |
| InChI | InChI=1S/C17H12F9NO3S/c18-14(19,20)10-27(31(29,30)13-4-2-1-3-5-13)12-8-6-11(7-9-12)15(28,16(21,22)23)17(24,25)26/h1-9,28H,10H2 |
| Molecular weight | 481.04 Da |
| AlogP | 4.756400000000003 |
| HBond acceptors | 4 |
| HBond donors | 1 |
| Atoms | 43 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.